Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,656   12.74  Index Moved Down -0.76%
GILD AMGN BIIB CELG Rentals Oil And Gas Natural Foods Semiconductor 
United States GSPC USD ...  |  Create Portfolios


Processing
Collecting data for GTXI

GTX Inc quote and profile

 
 Companies |  Insiders  | Dashboard  
     
6.23
  
STOCK
(0.12)  Macroaxis: -1.89 Down   1.89%  
Year To Date
2.626.35
Last 1 Month(s)
4.546.35
Trading Day 
6.27.14
May 22 2013 

Diversification Suggestion

Use GTX Inc to protect against small markets fluctuations. The stock experiences somewhat bearish sentiment, but market may correct it shortly
Analyze GTX Inc Trend or Check current 30 days GTX Inc correlation with market (S&P 500)
1 Month Beta -0.48  
Highest Price:  
Lowest Price:  
6.35  
4.54  
May 21 2013 
May 02 2013 
As returns on market increase, returns on owning GTX Inc are expected to decrease at a much smaller rate. During bear market, GTX Inc is likely to outperform the market.
GTX Inc Almost negative betaGTX Inc Beta Legend
GTXI United States Nasdaq
GTX Inc
Healthcare
Biotechnology
Benchmark S&P 500
http://www.gtxinc.com
Contact Number: 901. 523. 9700
Currency: USD - US Dollar
Traded on NASDAQ General Markets
    
Current Valuation314.02 M
Shares Outstanding62.94 M
Number of Shares Shorted2.64 M
Revenue6.67 M
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 United States NYSE   0.95 % Macroaxis: 0.95 Moved Down  
 
 United States SP 500   1.07 % Macroaxis: change 1.07 Moved Down  
 
 United States Russel   1.69 % Macroaxis: change 1.69 Moved Down  
 
 thisRed GTXI GTXI agains markets  1.89 % Macroaxis: change 1.89 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

GTX Inc Leadership

FACS MD Co-Founder, Vice Chairman, CEO and Member of Scientific Advisory Committee
Mitchell Steiner CEO, Vice Chairman of the Board
Joseph Hyde Independent Chairman of the Board
Marc Hanover President COO, MBA

GTX Inc Price and Market Media

The median price of GTX Inc for the period between Mon, Apr 22, 2013 and Wed, May 22, 2013 is 5.07 with a coefficient of variation of 9.3. The daily time series for the period is distributed with a sample standard deviation of 0.48, arithmetic mean of 5.18, and mean deviation of 0.41. The Stock received some media coverage during the period.
GTX Inc         SP 500
Price Growth (%)
 
1
GTx Inc. Is This Microcap Breaking Out04/26/2013Macroaxis: Seeking Alpha News
2
NVIDIA Corporation Move Is Smart But There a Caveat05/16/2013Macroaxis: News
3
PSivida Corporation And GTx 2 Of The Most Undervalued Biotec...05/21/2013Macroaxis: Seeking Alpha News

GTX Inc Summary

GTX Inc [GTXI] is traded on NASDAQ General Markets in USA. It is located in Memphis, TN and employs 88 people. The company currently falls under 'Small-Cap' category with current market capitalization of 399.66 M. GTX Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 62.94 M outstanding shares of which 2.64 M shares are currently shorted by private and institutional investors with about 11.3 trading days to cover.
GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions. more
Past Market
Over 30
Days
15
Out Of
100
 
Chance of
Less
Than
%
 
Follow GTX Inc with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add GTX Inc to your reader
 

GTX Inc Research Report

GTX Inc vs. Gilead

Correlation analysis and fundamentals comparison between GTX Inc and Gilead Sciences

GTX Inc Executives

Mark CPA CFO, Principal Accounting Officer, VP and Treasurer
Marc MBA Co-Founder and President and COO

GTX Inc Directors

J Glass Independent Director
Kenneth Robinson Independent Director
Barrington Furr Independent Director
Michael Carter Independent Director
Timothy Sear Independent Director, MBA

GTX Inc Fundamentals

Number of Shares Shorted vs Market Capitalization
Cash Flow from Operations vs Return On Asset
Number of Shares Shorted vs Current Liabilities
Beta vs Return On Asset

GTX Inc vs Competition

GTX Inc vs. Gilead Sciences Inc
GTX Inc vs. Amgen Inc
GTX Inc vs. Biogen Idec Inc
GTX Inc vs. Celgene Corporation
GTX Inc vs. Regeneron Pharmaceuticals Inc
GTX Inc vs. Alexion Pharmaceuticals Inc
GTX Inc vs. Vertex Pharmaceuticals Incorporated
GTX Inc vs. Illumina Inc
GTX Inc vs. BioMarin Pharmaceutical Inc
GTX Inc vs. Onyx Pharmaceuticals Inc

GTX Inc May 22 2013 Opportunity Range

Downside Deviation2.43
Information Ratio0.2218
Maximum Drawdown10.07
Value At Risk(3.31)
Potential Upside7.06

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium